<--- Back to Details
| First Page | Document Content | |
|---|---|---|
 Date: 2015-10-09 05:30:36Eli Lilly and Company Nicholas J. Vogelzang Karen H. Antman |
Add to Reading List |
| First Page | Document Content | |
|---|---|---|
Date: 2015-10-09 05:30:36Eli Lilly and Company Nicholas J. Vogelzang Karen H. Antman |
Add to Reading List |
Publications 2014 GERCOR 1. Could baseline health-related quality of life (QoL) predict overall survival in metastatic colorectal cancer? The results of the GERCOR OPTIMOX 1 study. Diouf M, Chibaudel B, Filleron T, Tourn